No specific molecular biological target

The designation "No specific molecular biological target" is applied to pharmacological agents that achieve their therapeutic effect through physical or chemical means rather than by binding to a specific biological macromolecule like a receptor or enzyme (Goodman & Gilman's The Pharmacological Basis of Therapeutics, 13th Ed). This category includes a diverse range of substances, such as antacids that neutralize stomach acid, osmotic laxatives that alter fluid balance in the gut, and surfactants that change surface tension (StatPearls, "Antacids", 2023). Because these drugs lack a specific protein target, their pharmacodynamics are governed by their concentration and chemical properties within a specific physiological compartment. While they are often used for symptomatic relief in gastrointestinal or toxicological contexts, they can influence the pharmacokinetics of co-administered drugs by altering pH or binding to other molecules (PubMed, PMID: 29024182). This classification is essential in drug discovery and bioinformatics to distinguish between targeted therapies and those with broad, non-specific modes of action. Examples of such agents include activated charcoal, which adsorbs toxins in the gastrointestinal tract, and magnesium sulfate, which acts as an osmotic agent. These treatments are generally characterized by a lack of receptor-mediated signaling pathways and do not typically exhibit the same type of structure-activity relationships seen with small molecule inhibitors or monoclonal antibodies.

Other names

Non-specific mechanismPhysicochemical actionNon-molecular targetUnspecified target

Physicochemical interaction including acid-base neutralization, osmotic gradient creation, adsorption, or surface tension alteration (Goodman & Gilman's The Pharmacological Basis of Therapeutics, 13th Ed).